SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Despite strong earnings, NVIDIA is trending down, sparking debate about an AI bubble. The community is actively discussing whether the drop is a market correction, profit-taking, or manipulation by institutional investors. Some also point to comments from a Fed official raising concerns about valuations as a contributing factor.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is experiencing high volatility as traders debate whether recent drops signal a larger market correction or just a temporary pullback, fueled by concerns around AI valuations and potential recession indicators. Community sentiment is mixed, with some anticipating a bounce while others brace for further declines, closely watching key support levels and VIX movements. The conversation includes speculation about the Fed's next moves and the impact of economic data on market direction.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending amid a sharp intraday reversal, prompting discussions about potential market manipulation and the strength of the AI sector following Nvidia's earnings; traders are actively debating whether this pullback represents a buying opportunity or the start of a deeper correction, with some pointing to possible Yen carry trade issues.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending following a strong Q3 earnings report that included raised FY26 guidance and a surge in e-commerce sales, with discussion around its potential move to the Nasdaq. Community talking points include whether Walmart is a safe haven during market volatility and the impact of potential government shutdowns on SNAP benefits and consumer spending at Walmart stores.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing a significant downturn, sparking debates about its role as a store of value and potential for further decline. Community discussions revolve around possible bottom levels, with some anticipating a substantial bounce while others fear a continued slide. The broader market context, including potential impacts from macroeconomic factors and liquidations, is also fueling uncertainty and volatility.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending following a target price increase from UBS and rising memory prices linked to AI data-center demand, fueling discussions about its growth potential. Community members are weighing the bullish outlook against concerns of an overbought condition after the stock's significant year-to-date gains. Discussions also focus on potential short-term pullbacks versus long-term opportunities in the semiconductor space.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending as it hits fresh 52-week lows, with the community debating whether it's a buying opportunity or if further downside is expected due to its correlation with Bitcoin. Despite the recent price drop, some traders are noting unusual call option activity, suggesting contrarian bullish bets, while others point to potential liquidation levels and debt concerns.

Safe & Green Holdings Corp. is a design and construction services company, which engages in the provision of code engineered cargo shipping containers. It operates through the following segments: Construction, Medical, Development, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Medical segment consists of joint venture COVID-19 laboratory operations. The Development segment focuses on real property development. The Corporate and Support segment includes general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments. The company was founded on December 29, 1993 and is headquartered in Miami, FL.

Safe & Green Holdings Corp

Safe & Green Holdings ($SGBX) is trending due to a potential short squeeze, with community members highlighting the high cost to borrow, significant short interest, and limited shares available for shorting. The stock has experienced a massive volume spike and intraday volatility, fueling discussions about a potential breakout and creating a battleground between bulls and bears. Some traders are drawing comparisons to other squeeze candidates and urging each other to hold firm.

MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. The Other Countries segment refers to Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, Bolivia, Honduras, Nicaragua, El Salvador, Guatemala, Paraguay, Uruguay, and the United States of America. Its products provide a mechanism for buying, selling, and paying as well as collecting, generating leads, and comparing lists through e-commerce transactions. The company was founded by Marcos Eduardo Galperin on October 15, 1999 and is headquartered in Montevideo, Uruguay.

MercadoLibre Inc

MELI is experiencing a significant downturn, with discussions focusing on a recent shelf filing and potential competition from Amazon as possible catalysts. The community is expressing concerns about the stock's performance, with some seeing the dip as a buying opportunity while others are wary of further declines. Broader macroeconomic factors and regional risks in Latin America are also being considered as contributing factors to the volatility.

iShares Bitcoin Trust ETF - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is trending due to Bitcoin's price volatility, sparking debates on whether to buy the dip or brace for further declines; some community members point to potential manipulation and significant ETF outflows as bearish signals, while others highlight oversold conditions and historical patterns as reasons for optimism, with key options levels around \$50 also in focus.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Omada Health (NASDAQ:OMDA) Coverage Initiated at BMO Capital Markets

BMO Capital Markets started coverage on shares of Omada Health in a research report on Thursday. They set an "outperform" rating and a $27.00 price target on the stock...

<ul class="summary-bullets"><li>Morgan Stanley, Evercore ISI, and Barclays raised price targets to between $28–$32, citing Omada’s revenue growth and its first positive adjusted EBITDA.</li><li>The company plans to integrate GLP-1 prescribing and medication management into its weight-health program, expanding its digital-care platform.</li><li>Retail traders highlighted the company’s strong balance sheet, high gross margins, and operating leverage as signs of growth potential.</li></ul><p>Retail chatter on Omada Health surged over the weekend after several brokerages raised price targets following stronger-than-expected third-quarter (Q3) results and the company’s new GLP-1 prescribing initiative for its weight-health program.</p><h2 class="st-heading-2"><strong>Analyst Upgrades</strong></h2><p>Morgan Stanley raised its price target on Omada Health to $32 from $30 and kept an ‘Overweight’ rating, citing 49% year-over-year revenue growth, an 11% beat versus consensus, and the company’s first quarter of positive adjusted EBITDA. The firm said momentum continues and highlighted the addition of GLP-1 prescribing to Omada’s offering as a key development.</p><p>Evercore ISI increased its price target to $28 from $27 and maintained an ‘Outperform’ rating, noting that Q3 revenue and EBITDA beat expectations and full-year 2025 guidance was raised.</p><p>Barclays lifted its price target to $29 from $28 and reiterated an ‘Overweight’ rating, describing Omada’s results as “another beat and raise quarter.”</p><h2 class="st-heading-2"><strong>Q3 Review</strong></h2><p>Omada reported revenue of $68 million, ahead of consensus estimates of $61.2 million. Total members rose 53% to 831,000, while the company’s net loss narrowed to $3 million from $9 million a year earlier. Omada achieved its first positive adjusted EBITDA of $2 million, compared with a $5 million loss in the prior-year period.</p><p>Gross margin improved to 66%, and cash and cash equivalents totaled $199 million at quarter-end.</p><p>CEO Sean Duffy said the results demonstrate “the strength of Omada’s multi-product platform” as the company deepens its innovation in GLP-1 care options and AI tools aimed at delivering “sustainable outcomes” and “cost savings” for customers.</p><h2 class="st-heading-2"><strong>GLP-1 Expansion And Product Updates</strong></h2><p>The company announced plans to integrate prescribing and medication management for anti-obesity medications, including GLP-1s, into its weight-health program.</p><p>Omada also launched Meal Map, an AI-driven nutrition platform that prioritizes nutrient quality over calorie tracking, and published results from its 30th peer-reviewed research study, which showed savings generated from its Joint &amp; Muscle Health program. Additional results showed that members largely sustained their weight a year after stopping GLP-1 treatment.</p><h2 class="st-heading-2"><strong>Financial Outlook</strong></h2><p>Omada raised its FY25 revenue guidance to $251.5 million-$254.5 million, up from a prior range of $235 million–$241 million, and now expects adjusted EBITDA between breakeven and a $2 million loss, compared with earlier guidance for a $9 million–$5 million loss.</p><h2 class="st-heading-2"><strong>Stocktwits Traders Say Omada’s GLP-1 Plan Shows Real Execution</strong></h2><p>On Stocktwits, retail sentiment for Omada was ‘extremely bullish’ amid ‘extremely high’ message volume.</p><figure class="image"><img style="aspect-ratio:963/138;" src="https://news.stocktwits-cdn.com/omda_ss_jpg_d120b63835.webp" alt="omda ss.jpg" width="963" height="138"><figcaption>OMDA sentiment and message volume as of November 9 | Source: Stocktwits</figcaption></figure><p>One user said some companies “just mention GLP-1 to garner headlines” without clear execution plans, but noted that Omada Health already has case studies, proof-of-concept, and “the balance sheet to boost this up.” They added that the business model is proven and now depends on strong marketing to capture the opportunity.</p><p><stembedurl>https://stocktwits.com/Jasooon/message/635551904</stembedurl></p><p>Another user said the company’s financials “prove it,” pointing to high gross margins, positive adjusted EBITDA, and improved cash flow as signs of operating leverage and a “stellar management team.”</p><p><stembedurl>https://stocktwits.com/Jasooon/message/635551456</stembedurl></p><p><a href="https://stocktwits.com/symbol/OMDA">Omada Health’s stock</a> has declined 12% so far in 2025.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, the Omada Health logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Omada Health Stock Jumps Into Retail Focus As Wall Street Lifts Price Targets After ‘Beat And Raise’ Quarter, GLP-1 Push

Morgan Stanley, Evercore ISI, and Barclays raised price targets to between $28–$32, citing Omada’s revenue growth and its first positive adjusted EBITDA.

Equity

Teacher Retirement System of Texas Acquires New Stake in Omada Health, Inc. $OMDA

Teacher Retirement System of Texas bought a new position in Omada Health, Inc. (NASDAQ:OMDA - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities...

Omada Health (NASDAQ:OMDA) Price Target Raised to $29.00

Barclays increased their target price on shares of Omada Health from $28.00 to $29.00 and gave the stock an "overweight" rating in a research report on Friday...

Omada Health (NASDAQ:OMDA) Trading Down 11.1% - Time to Sell?

Omada Health (NASDAQ:OMDA) Trading Down 11.1% - Here's Why...

Omada Health (NASDAQ:OMDA) Price Target Raised to $28.00

Evercore ISI increased their target price on Omada Health from $27.00 to $28.00 and gave the stock an "outperform" rating in a research report on Friday...

Needham & Company LLC Issues Positive Forecast for Omada Health (NASDAQ:OMDA) Stock Price

Needham & Company LLC increased their price objective on shares of Omada Health from $26.00 to $28.00 and gave the stock a "buy" rating in a research note on Friday...

Omada Health (NASDAQ:OMDA) Releases Quarterly Earnings Results, Beats Estimates By $0.21 EPS

Omada Health (NASDAQ:OMDA - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.24) by $0.21...

Compared to Estimates, Omada Health, Inc. (OMDA) Q3 Earnings: A Look at Key Metrics

The headline numbers for Omada Health, Inc. (OMDA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows

The announcement expands the offerings under the company's weight management program as its membership grows to more than 100,000...

Omada Health, Inc. engages in the provision of digital health services. It offers online diabetes and obesity prevention programs, health coaching, and integration of web, mobile, and smart devices. The company was founded by Andrew DiMichele, Adrian James, and Sean Duffy on April 25, 2011 and is headquartered in South San Francisco, CA.

Current Price	$18.36
Prev Close	$19.11
Open	$19.33
Dividend Yield	N/A
50-Day Moving Average	$23.17
Beta	0.17
Avg. Volume	330,965.74
PE Ratio	-41.10

52-Week High	$28.40
52-Week Low	$14.14
Market Capitalization	$1.11B
EPS (Annual)	-$0.8456
Price to Book	5.09
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

OMDA
Omada Health, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OMDA News

OMDAOmada Health, Inc.